|
|
|
Stem Cell Related Patent Number US6989248
| Title: | Methods of use of compounds which inhibit the stem cell signaling pathway | | Inventors: | Longley, B. Jack; Hamden, CT, USA | | Summary: | This invention describes novel compounds which inhibit the stem cell factor signaling pathway, methods and uses thereof. Further disclosed are constituents of the compounds as well as the means by which signaling pathways are inhibited. Therapeutic applications are included such as in the treatment of hyperpigmentation, asthma, cutaneous inflammation, anaphylaxis and bronchospasm, mastocytosis, tumors which express activated kit, and conception. Claims of the invention include a specific suitability to the treatment and prevention of contact dermatitis, resulting from the effective inhibition of the specific stem cell signaling pathway addressed herein. Further described are the precise means of administration for delivering to a patient an antibody or portion thereof that binds to kit protein in an amount effective to inhibit the kinase enzymatic reaction of kit protein, which thereby inhibits the stem cell factor signaling pathway. | | Abstract: | This invention provides a method of preventing or treating in a subject contact dermatitis which comprises administering to the subject an amount of a compound capable of inhibiting the stem cell factor signaling pathway effective to prevent or treat contact dermatitis so as to thereby prevent or treat contact dermatitis in the subject. This invention also provides a methods of preventing or treating in a subject hyperpigmentation, asthma, cutaneous inflammation, anaphylaxis and bronchospasm, mastocytosis, tumors which express activated kit, and conception. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6989248 | | Application Number: | US1999000474478 | | Date Filed: | 29/12/1999 | | Date Published: | 24/01/2006 | | Assignee: | The Trustees of Columbia University in the City of New York, New York, NY, USA |
|
|
